Shares of Applied Therapeutics, Inc. (APLT) have traded between $7.95 – 45.73. The next earnings date is set for Feb 12, 2020. Let’s see how its prospects are shaping up.

What does Applied Therapeutics, Inc.(APLT) do?

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

APLT Insider Trading Insight

On 2019-05-16, Alexandria Real Estate Equities Inc 10% purchased 975,000 shares of APLT. That represents a value of $975,000. Not to be outdone, on 2019-05-16, Shendelman Shoshana P – Purchase bought125,000 shares of APLT. These insiders are clearly in the know because they work closely with the company.

The PUMP Consensus Price Target

The mean recommendation of ProPetro Holding Corp. from top Wall Street analysts is a Moderate Buy. That is based on 9 analysts who work on the Street. Based on 9 analysts offering 12 month price targets for Propetro Holding in the last 3 months. The average price target is $13.15 with a high forecast of $18.00 and a low forecast of $9.50. The average price target represents a 20.20% increase from the last price of $10.94. Last week, several articles were published in financial papers about PUMP and 39% Bearish while 61% Bullish.

PUMP Intraday Trading

PUMP is due to report earnings on Feb 25, 2020. In the last year the price has ranged from 7.08 – 25.38. Recently, Armour Spencer D III sold 22,500 shares of PUMP. He is a $388,125 shareholder in PUMP.